The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation
Open accessAbstract
AIMS: To estimate costs of admission and costs incurred on an annual basis by patients with atrial fibrillation (AF) in Greece, Italy, Poland, Spain, and the Netherlands. METHODS AND RESULTS: The Euro Heart Survey on AF enrolled 5333 patients with AF in 35 European countries in 2003 and 2004. This was a bottom-up cost study conducted for the five largest contributors in terms of patients enrolled. Quantities of resource use during the enrolment admission and during 1-year follow-up were inferred from survey data and multiplied by national unit costs in order to estimate per patient costs associated with AF for each country. Mean costs of inpatient admission of an AF patient were estimated at euro1363, euro5252, euro2322, euro6360, and euro6445 and mean costs incurred on an annual basis at euro1507, euro3225, euro1010, euro2315, and euro2328 in Greece, Italy, Poland, Spain, and the Netherlands, respectively. Inpatient care and interventional procedures were identified as the main drivers of costs, accounting for more than 70% of total annual costs in all five countries. CONCLUSION: Estimates of the economic burden posed by AF are critical in light of the increasing importance of AF as a public health problem.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205
Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study
Heeringa, J., van der Kuip, D. A. M., Hofman, A., Kors, J. A., van Herpen, G., Stricker, B. H. C., Stijnen, T., Lip, G. Y. H., & Witteman, J. C. M. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi825 · Cited by 1,939
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study
Wolf, P. A., Dawber, T. R., Thomas, H. E., & Kannel, W. B. (1978) · Neurology · doi:10.1212/wnl.28.10.973 · Cited by 1,526
Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK
Stewart, S., Murphy, N., Walker, A., McGuire, A., & McMurray, J. J. V. (2004) · Heart · doi:10.1136/hrt.2002.008748 · Cited by 590 · cited 3×
“Vitamin K antagonist 121 (48) 383 (59) 113 (56) 494 (69) 473 (69) Other antithrombotic treatment 66 (26) 195 (30) 29 (14) 184 (26) 126 ( 18 ) Anti-arrhythmic/rate control treatment 156 (62) 533 (70) 143 (70) 550 (76) 532 (78)”
InfluentialWattigney, W. A., Mensah, G. A., & Croft, J. B. (2003) · Circulation · doi:10.1161/01.cir.0000083722.42033.0a · Cited by 505
Majeed, A., Moser, K., & Carroll, K. (2001) · Heart · doi:10.1136/heart.86.3.284 · Cited by 253
Cited by
Krijthe, B. P., Kunst, A., Benjamin, E. J., Lip, G. Y. H., Franco, O. H., Hofman, A., Witteman, J. C. M., Stricker, B. H., & Heeringa, J. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht280 · Cited by 1,419
Schnabel, R. B., Sullivan, L. M., Levy, D., Pencina, M. J., Massaro, J. M., D'Agostino, R. B., Newton-Cheh, C., Yamamoto, J. F., Magnani, J. W., Tadros, T. M., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60443-8 · Cited by 1,041
Global epidemiology of atrial fibrillation
Rahman, F., Kwan, G. F., & Benjamin, E. J. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.118 · Cited by 731
Atrial fibrillation: Profile and burden of an evolving epidemic in the 21st century
Ball, J., Carrington, M. J., McMurray, J. J. V., & Stewart, S. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.12.093 · Cited by 630
Hendriks, J. M. L., de Wit, R., Crijns, H. J. G. M., Vrijhoef, H. J. M., Prins, M. H., Pisters, R., Pison, L. A. F. G., Blaauw, Y., & Tieleman, R. G. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs071 · Cited by 409
“It is becoming an extremely costly public health problem,(3,4) with hospitalization as the primary cost driver.(5) Atrial fibrillation is often inadequately managed due to deficient adherence to guidelines.”
BackgroundThe cost of illness of atrial fibrillation: a systematic review of the recent literature
Wolowacz, S. E., Samuel, M., Brennan, V. K., Jasso-Mosqueda, J. G., & Van Gelder, I. C. (2011) · Europace · doi:10.1093/europace/eur194 · Cited by 263
Aliot, E., Breithardt, G., Brugada, J., Camm, J., Lip, G. Y. H., Vardas, P. E., Wagner, M., & for the Atrial Fibrillation AWareness And Risk Education (AF AWARE) group [comprising the Atrial Fibrillation Association (AFA), T. E. H. R. A. (. (2010) · Europace · doi:10.1093/europace/euq109 · Cited by 119
A review of the cost of atrial fibrillation
Wodchis, W. P., Bhatia, R. S., Leblanc, K., Meshkat, N., & Morra, D. (2012) · Value in Health · doi:10.1016/j.jval.2011.09.009 · Cited by 109
Hendriks, J., Tomini, F., van Asselt, T., Crijns, H., & Vrijhoef, H. (2013) · Europace · doi:10.1093/europace/eut055 · Cited by 100
Self-citationWhat are the costs of atrial fibrillation?
Blomstrom Lundqvist, C., Lip, G. Y. H., & Kirchhof, P. (2011) · Europace · doi:10.1093/europace/eur087 · Cited by 42
Zubaid, M., Rashed, W. A., Alsheikh-Ali, A. A., Al-Zakwani, I., AlMahmeed, W., Shehab, A., Sulaiman, K., Qudaimi, A. A., Asaad, N., & Amin, H. (2015) · Angiology · doi:10.1177/0003319714536980 · Cited by 29
“Half of the financial costs of AF management relates to hospital admissions.(4,29) Possible reasons for the high admission rate in our population include tendency of ED physicians to defer decisions regarding management strategy to admitting doctors, preference to cardiovert patients while in-hospital, unavailability…”
Background
Metadata
- Authors
- Ringborg, A., Nieuwlaat, R., Lindgren, P., Jonsson, B., Fidan, D., Maggioni, A. P., Lopez-Sendon, J., Stepinska, J., Cokkinos, D. V., & Crijns, H. J. G. M.
- Venue
- Europace
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-03-07
- Volume
- 10
- Issue
- 4
- Pages
- 403-411
- ISSN
- 1099-5129 (ISSN-L)
- 1532-2092
- OpenAlex
- W2111466538
- Cited by
- 230
- References
- 6
- FWCI
- 9.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.